BNO — Bionomics Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- AU$14.69m
- -AU$15.40m
- AU$0.26m
Annual balance sheet for Bionomics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2018 June 30th | C2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 24.9 | 14 | 4.58 | 28.9 | 33.6 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 9 | 8.72 | 2.98 | 1.13 | 6.78 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 35.9 | 25.1 | 8.33 | 30.9 | 41.8 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 2.74 | 2.51 | 1.05 | 0.871 | 0.675 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Total Assets | 65.1 | 53.7 | 34.5 | 54.3 | 65.3 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 13.3 | 13.8 | 8.27 | 2.36 | 3.36 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 48.1 | 37.2 | 21.8 | 6.67 | 8.4 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 17 | 16.5 | 12.7 | 47.6 | 56.9 |
| Total Liabilities & Shareholders' Equity | 65.1 | 53.7 | 34.5 | 54.3 | 65.3 |
| Total Common Shares Outstanding |